Olmediqul HCT Tablet 10/40/12.5 mg

Adult dose

Take one tablet once daily with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40mg.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age, and the use of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be immediately stopped if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this medication or its components, patients with certain heart, kidney, or liver diseases, pregnant or breastfeeding women, and patients with some electrolyte imbalances. In patients with low blood volume or salt deficiency, hypotension may occur; therefore, the patient's condition should be carefully observed, and appropriate measures should be taken if necessary. Patients with impaired kidney function, kidney transplant patients, patients with renovascular hypertension, and patients with liver disease should use this medication with caution due to its effects. Since this medication lowers blood pressure, elderly patients or those with cardiovascular diseases need to take special precautions, and it is important to monitor for symptoms of hypotension during the initiation of treatment. This medication can cause electrolyte imbalances, such as fluctuations in potassium levels, hypokalemia, hypercalcemia, and hypomagnesemia, so regular blood tests are necessary. Photosensitivity reactions may occur, so care should be taken when exposed to sunlight, and if symptoms such as skin rashes or itching appear, immediate consultation with medical personnel is advised. This medication may interact with other antihypertensives, diuretics, lithium, NSAIDs, etc., so it is essential to inform healthcare professionals of any other medications being taken. Use of this medication is not recommended while breastfeeding, and if necessary, it is advisable to stop breastfeeding or discontinue the medication. Safety and efficacy have not been established for pediatric patients under the age of 18, so its use is not recommended. In case of overdose, symptoms such as hypotension, palpitations, and electrolyte abnormalities may occur, and immediate medical attention is required.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with respiratory distress and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, lightning-like headache, seizures, confusion, visual disturbances, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to prevent air or moisture from entering and should preferably be kept at room temperature between 1°C and 30°C. This way, the medication's efficacy can be maintained for a long time.

Appearance

Round film-coated tablet, reddish-gray in color

Package unit

28 tablets (14 tablets/PTP X 2)/Carton